Scholarly Index
Peter B. Bach
CCC Diagnostics (United States); 24,235 total citations; 301 total publications; best world rank #36
CCC Diagnostics (United States)
24,235Total citations
301Total publications
69H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Pharmaceutical Economics and Policy | Lifetime | 36 | US 24 | 99.04 |
| Economic and Financial Impacts of Cancer | Lifetime | 42 | US 33 | 99.18 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 286 | US 138 | 99.14 |
| Lung Cancer Diagnosis and Treatment | Lifetime | 352 | US 167 | 98.98 |
| Healthcare Policy and Management | Lifetime | 298 | US 223 | 98.36 |
| Lung Cancer Treatments and Mutations | Lifetime | 664 | US 313 | 98.60 |
| Global Cancer Incidence and Screening | Lifetime | 625 | US 333 | 97.19 |
| Primary Care and Health Outcomes | Lifetime | 813 | US 466 | 96.11 |
| Healthcare cost, quality, practices | Lifetime | 500 | US 273 | 94.28 |
| Medication Adherence and Compliance | Lifetime | 439 | US 248 | 94.33 |
| Pharmaceutical industry and healthcare | Lifetime | 336 | US 202 | 90.55 |
| Pharmaceutical Economics and Policy | 2021-2025 | 240 | US 92 | 87.87 |
| Economic and Financial Impacts of Cancer | 2021-2025 | 534 | US 331 | 87.70 |
| Pharmaceutical industry and healthcare | 2021-2025 | 46 | US 20 | 86.06 |
| Ureteral procedures and complications | 2021-2025 | 595 | US 123 | 71.90 |